1. Home
  2. ABEO vs FSBW Comparison

ABEO vs FSBW Comparison

Compare ABEO & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • FSBW
  • Stock Information
  • Founded
  • ABEO 1974
  • FSBW 1936
  • Country
  • ABEO United States
  • FSBW United States
  • Employees
  • ABEO N/A
  • FSBW N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • FSBW Banks
  • Sector
  • ABEO Health Care
  • FSBW Finance
  • Exchange
  • ABEO Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • ABEO 350.2M
  • FSBW 324.8M
  • IPO Year
  • ABEO 1980
  • FSBW 2012
  • Fundamental
  • Price
  • ABEO $6.88
  • FSBW $42.34
  • Analyst Decision
  • ABEO Strong Buy
  • FSBW Hold
  • Analyst Count
  • ABEO 6
  • FSBW 1
  • Target Price
  • ABEO $18.17
  • FSBW $44.00
  • AVG Volume (30 Days)
  • ABEO 687.8K
  • FSBW 16.6K
  • Earning Date
  • ABEO 08-14-2025
  • FSBW 10-21-2025
  • Dividend Yield
  • ABEO N/A
  • FSBW 2.66%
  • EPS Growth
  • ABEO N/A
  • FSBW N/A
  • EPS
  • ABEO 0.99
  • FSBW 4.15
  • Revenue
  • ABEO $400,000.00
  • FSBW $139,676,000.00
  • Revenue This Year
  • ABEO N/A
  • FSBW $9.62
  • Revenue Next Year
  • ABEO $339.63
  • FSBW $5.35
  • P/E Ratio
  • ABEO $7.02
  • FSBW $10.14
  • Revenue Growth
  • ABEO N/A
  • FSBW 0.61
  • 52 Week Low
  • ABEO $3.93
  • FSBW $34.61
  • 52 Week High
  • ABEO $7.54
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 56.13
  • FSBW 58.69
  • Support Level
  • ABEO $6.74
  • FSBW $41.95
  • Resistance Level
  • ABEO $7.05
  • FSBW $42.89
  • Average True Range (ATR)
  • ABEO 0.26
  • FSBW 1.05
  • MACD
  • ABEO -0.03
  • FSBW 0.22
  • Stochastic Oscillator
  • ABEO 30.95
  • FSBW 84.76

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: